GALLBLADDER CARCINOMA
Clinical trials for GALLBLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GALLBLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets hard-to-treat HER2+ gut cancers
Disease control OngoingThis study is testing whether a drug called tucatinib can be safely combined with other cancer medicines (trastuzumab, chemotherapy, and pembrolizumab) to treat HER2-positive cancers of the digestive system. About 40 adults with advanced stomach, bowel, or gallbladder cancer are …
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 09:20 UTC
-
New drug combo shows promise for Tough-to-Treat biliary cancers
Disease control OngoingThis study tests whether adding the targeted drug selumetinib to standard chemotherapy (cisplatin and gemcitabine) helps shrink tumors better than chemo alone in people with advanced bile duct or gallbladder cancer. About 57 adults who have not had prior treatment for their cance…
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 17, 2026 09:08 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC